168 related articles for article (PubMed ID: 36781839)
1. m
Guan H; Tian K; Luo W; Li M
Cell Death Dis; 2023 Feb; 14(2):120. PubMed ID: 36781839
[TBL] [Abstract][Full Text] [Related]
2. Glycolysis and tumor progression promoted by the m
Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
[TBL] [Abstract][Full Text] [Related]
3. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
[TBL] [Abstract][Full Text] [Related]
4. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
[TBL] [Abstract][Full Text] [Related]
5. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
6. N
Liu Z; Wang T; She Y; Wu K; Gu S; Li L; Dong C; Chen C; Zhou Y
Mol Cancer; 2021 Aug; 20(1):105. PubMed ID: 34416901
[TBL] [Abstract][Full Text] [Related]
7. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma.
Yang T; Shen P; Chen Q; Wu P; Yuan H; Ge W; Meng L; Huang X; Fu Y; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
J Exp Clin Cancer Res; 2021 Aug; 40(1):261. PubMed ID: 34416910
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 2 mRNA binding protein 2 promotes aerobic glycolysis and cell proliferation in pancreatic ductal adenocarcinoma via stabilizing GLUT1 mRNA.
Huang S; Wu Z; Cheng Y; Wei W; Hao L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):743-752. PubMed ID: 31089713
[TBL] [Abstract][Full Text] [Related]
10. METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation.
Lin C; Li T; Wang Y; Lai S; Huang Y; Guo Z; Zhang X; Weng S
Cell Death Dis; 2023 Mar; 14(3):221. PubMed ID: 36977668
[TBL] [Abstract][Full Text] [Related]
11. METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.
Zhu L; Li B; Li R; Hu L; Zhang Y; Zhang Z; Jiang S; Zhang X
Cell Oncol (Dordr); 2023 Oct; 46(5):1529-1541. PubMed ID: 37178367
[TBL] [Abstract][Full Text] [Related]
12. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.
Kong Y; Li Y; Luo Y; Zhu J; Zheng H; Gao B; Guo X; Li Z; Chen R; Chen C
Mol Cancer; 2020 May; 19(1):82. PubMed ID: 32366257
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
Wang X; Li X; Wei X; Jiang H; Lan C; Yang S; Wang H; Yang Y; Tian C; Xu Z; Zhang J; Hao J; Ren H
Signal Transduct Target Ther; 2020 Apr; 5(1):38. PubMed ID: 32300119
[TBL] [Abstract][Full Text] [Related]
14. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942.
Wong CH; Lou UK; Li Y; Chan SL; Tong JH; To KF; Chen Y
Cancer Res; 2020 Jun; 80(11):2138-2149. PubMed ID: 32217695
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis.
Tsukamoto M; Imai K; Ishimoto T; Komohara Y; Yamashita YI; Nakagawa S; Umezaki N; Yamao T; Kitano Y; Miyata T; Arima K; Okabe H; Baba Y; Chikamoto A; Ishiko T; Hirota M; Baba H
Cancer Sci; 2019 Jan; 110(1):310-320. PubMed ID: 30426611
[TBL] [Abstract][Full Text] [Related]
16. CSTF2 mediated mRNA N
Zheng Y; Li X; Deng S; Zhao H; Ye Y; Zhang S; Huang X; Bai R; Zhuang L; Zhou Q; Li M; Su J; Li R; Bao X; Zeng L; Chen R; Zheng J; Lin D; He C; Zhang J; Zuo Z
Nat Commun; 2023 Oct; 14(1):6334. PubMed ID: 37816727
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circ_0047744 suppresses the metastasis of pancreatic ductal adenocarcinoma by regulating the miR-21/SOCS5 axis.
Xie H; Zhao Q; Yu L; Lu J; Peng K; Xie N; Ni J; Li B
Biochem Biophys Res Commun; 2022 May; 605():154-161. PubMed ID: 35334414
[TBL] [Abstract][Full Text] [Related]
18. GNG12 regulates PD-L1 expression by activating NF-κB signaling in pancreatic ductal adenocarcinoma.
Li J; Jin C; Zou C; Qiao X; Ma P; Hu D; Li W; Jin J; Jin X; Fan P
FEBS Open Bio; 2020 Feb; 10(2):278-287. PubMed ID: 31898405
[TBL] [Abstract][Full Text] [Related]
19. Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer.
Deng H; Yao H; Zhou S; He C; Huang Y; Li Y; Chen H; Shu J
Mol Cell Probes; 2024 Feb; 73():101948. PubMed ID: 38122949
[TBL] [Abstract][Full Text] [Related]
20. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
